Category Archives: Pharmacogenomics

Katherine CappsMolly Ekstrand, BPharm, BCACP, AE-C

Pharmacists well understand that medication is part of the daily lives of many Americans. In fact, studies show nearly 75% of visits to physician offices and hospital outpatient clinics involve medication therapy, and almost 30% of adults take five or more medications. Unfortunately, suboptimal medication use leads to at least 275,000 deaths annually and costs more than $528 billion.

Recently, our organization, The Get the Medications Right (GTMRx) Institute, in Tysons Corner, Va., released a report outlining steps for medication management reform, including a call for comprehensive medication management, or CMM. This comprehensive management is an evidence-based process of care that personalizes the approach, resulting in better care, reduced costs, and improved patient satisfaction and provider work life.

The report, the GTMRx Blueprint for Change, includes recommendations outlining how each stakeholder can get involved to improve patient carefrom physicians to clinical pharmacists, health plan sponsors, providers, consumer groups, employers as health plan sponsors, and policymakers.Many things need to change, but technology and information technology (IT) capabilities are central in the challenge for reform.

Here, we outline four health IT categories to achieve medication optimization through CMM, enabling a broad practice adoption of a systematic approach to medication use throughout the continuum of care. Software supports the practice management systems developed around CMM workflows and thought processes, driving consistency of the CMM service. Within each of these categories, organizations will undergo a journey toward maturity. However, considerations in each of these categories are foundational.

1. Clinical Decision Support Tools (at the point of care): Access to diagnostic results, clinical notes, patient status and other clinical information allows care teams to fulfill important activities in the CMM process. This information offers insight into patients experiencing medication therapy problems, and it helps the clinicians determine whether or not the patient has achieved the clinical goals of therapy. Having the ability to evaluate actual use patterns of all medications (e.g., over the counter, supplements, prescribed drugs and biologics) also is important. This full view of information is essential for the medication expert to properly assess each medication for appropriateness, focusing on the achievement of the clinical goals for each therapy. Organization and interpretation of these data in a medication-centric workflow can improve the efficiency and efficacy of clinical decision making. A medication-related dashboard should have the ability to support anyone on the care team, allowing them to make simple, streamlined decisions about a patients medication therapy. This dashboard should include objective data that help clinicians decide whether a patient needs a higher level statin, the blood pressure medicine should be increased, or pharmacogenomic data are needed to assess the safety or efficacy of the medications.

2. Population Health and Risk Stratification Tools: Health care resources are finite. There are certain patient populations that benefit more from CMM services. Tools that integrate data from electronic health records (EHRs), pharmacies, health plans and other reliable sources can provide the foundation for deployment of comprehensive risk models. Risk modeling tools allow payor, provider or value-based networks to easily identify the patients who are at risk and will benefit most from CMM services. Health systems, pharmacies, payors and prescribers should also have the ability to proactively reach out and invite at-risk patients to participate in CMM services, effectively automating a process and decreasing administrative burden from the point-of-care clinician.

3. Patient Engagement and Care Coordination Tools: Health IT should enable and facilitate the exchange of information between the patient and care team. Patients gather information in various forms that can inform clinical decisions regarding medication therapy. The tools should have the ability to integrate the digital therapeutic health information from a patient with the pharmacogenomic data that clinicians currently receive as a separate, cumbersome report. These types of information would come together in an EHR in a usable fashion. Health IT can facilitate bidirectional communication between the pharmacist, clinician and patient. Clinicians should have the ability to effectively and efficiently communicate across the continuum of care. In many cases, the patients care team, including the pharmacist providing comprehensive medication management, are not colocated and do not share a single EHR platform. Its imperative that health IT has the ability to enable bidirectional, secure health-related data exchange to promote optimal medication use.

4. Health IT Supporting Economic, Clinical and Humanistic Outcomes: Purpose-built software can drive consistency and demonstrate the value of CMM practice. Software ensures the capture of compliance and regulatory reporting requirements unique to CMM services. The tools should have the ability to allow the team to identify medication therapy problems in a systematic way, with the ability to gather and analyze information across systems and care settings. The tools should have the ability to track participation, offer point-of-care insight to the clinician, and, in order to efficiently identify medication therapy problems, record the defined medication care plan and steps toward resolution.

CMM services can be correlated with broader changes in health status or health care utilization patterns, thus demonstrating contribution and value to the broader health care system. However, optimizing medication use through CMM in practice truly and wholly relies on having the right data, at the right time, at the point of care and available to the entire team.

Ms. Capps is the co-founder and executive director of the GTMRx Instituteusvuwtdtxr, a catalyst for change that brings critical stakeholders together, bound by the urgent need to get the medications right. Ms. Ekstrand is a distinguished fellow at GTMRx.

See original here:
The Formative Four: Top Health IT Capabilities That Will Improve Medication Management - Pharmacy Technology Report

The strategy analysis on Global Pharmacogenomics Market gives insights of market size, trends, share, growth, development plans, Investment Plan, cost structure, and drivers analysis. With precise data covering all key aspects of the existing market, this report offers existing data of leading manufacturers. The Pharmacogenomics market report covers marketing channels and market positioning to potential growth strategies, providing in-depth analysis for new competitors or exists competitors in the Pharmacogenomics industry. The Report Gives Detail Analysis on Market concern Like Pharmacogenomics Market share, CAGR Status, Market demand, and up to date Market Trends with key Market segments. The report provides key statistics on the market status of the Pharmacogenomics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of the Pharmacogenomics market covering all important parameters.

Note: *The Download PDF brochure only consists of Table of Content, Research Framework, and Research Methodology.

Request A PDF Sample Copy Pharmacogenomics Market Report Click here: https://www.coherentmarketinsights.com/insight/request-pdf/1053

Global Pharmacogenomics market 2020-2026: Competitive Analysis

The Pharmacogenomics market report designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support. We provide a detailed analysis of key players operating in the global Pharmacogenomics market, including key players such as Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Qiagen N.V., Pacific Biosciences of California, Inc., Diatech Pharmacogenetics Srl and Assurex Health Inc.

Scope of Pharmacogenomics Market:

The Pharmacogenomics market was valued at XX Million US$ in 2020 and is projected to reach XX Million US$ by 2027, at a CAGR of XX% during the forecast period. In this study, 2020 has been considered as the base year and 2020 to 2027 as the forecast period to estimate the market size for Pharmacogenomics.

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Pharmacogenomics Market which would mention How the Covid-19 is Affecting the Pharmacogenomics Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Pharmacogenomics Players to fight Covid-19 Impact.

The report also focuses on global major leading industry players of Global Pharmacogenomics market providing information such as company profiles, product picture, and specification, price, capacity, cost, production, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis are also carried out. With tables and figures helping analyze worldwide Global Pharmacogenomics market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. In general, the research report is a compilation of key data with regards to the competitive landscape of this vertical and the multiple regions where the business has successfully established its position. The report provides detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the Pharmacogenomics market. The Pharmacogenomics Market Report analyzes opportunities in the overall Pharmacogenomics market for stakeholders by identifying the high growth segments.

The scope of the report is limited to the application of the type and distribution channel. The regions considered in the scope of the report include North America Country (United States, Canada), South America, Asia Country (China, Japan, India, Korea), Europe Country (Germany, UK, France, Italy), Other Country (Middle East, Africa, GCC). This report presents the worldwide Pharmacogenomics market size (value, production, and consumption), splits the breakdown (data status 20152019 and forecast to 2027), by manufacturers, region, type, and application.

Market segment by Type, the product can be split into:Product Type Segmentation: Epicel, IntegraIndustry Segmentation: Chemical, Cosmetic, Pharmaceutical

The Global Pharmacogenomics Market report analyses the production of goods, supply, sales, and the current status of the market in a detailed manner. Furthermore, the report examines the production shares and market product sales, as well as the capacity, production capacity, trends in sales, cost analysis, and revenue generation. Several other factors such as import/export status, industrial statistics, demand and supply ratio, gross margin, and industry chain structure have also been studied in the Global Pharmacogenomics Market report.

The report comprehends precise analytical information related to market forecasts for several upcoming years. The report also includes the particulars about the valuation of macro and microelements significant for the growth of already established Pharmacogenomics Market contenders and emerging new companies. The report uses SWOT analysis for the growth assessment of the outstanding Pharmacogenomics Market players. It also analyzes the most recent enhancements while estimating the expansion of the foremost Pharmacogenomics Market players. Additionally, the key product category and segments along with sub-segments of the global Pharmacogenomics Market are studied in the global Market research.

What Reports Provides

Full in-depth analysis of the parent market Important changes in market dynamics Segmentation details of the market Former, on-going, and projected market analysis in terms of volume and value Assessment of niche industry developments Market share analysis Key strategies of major players Emerging segments and regional markets Testimonials to companies in order to fortify their foothold in the market.

Further, in the research report, the following points are included along with an in-depth study of each point:

* Production Analysis Production is analyzed with respect to different regions, types, and applications. Here, the price analysis of various Market key players is also covered.* Sales and Revenue Analysis Both, sales and revenue are studied for the different regions of the global market. Another major aspect, price, which plays an important part in the revenue generation is also assessed in this section for the various regions.* Supply and Consumption In continuation of sales, this section studies the supply and consumption of the Market. This part also sheds light on the gap between supply and consumption. Import and export figures are also given in this part.* Other analyses Apart from the information, trade and distribution analysis for the Market, the contact information of major manufacturers, suppliers and key consumers is also given. Also, SWOT analysis for new projects and feasibility analysis for new investment are included.

Reasons to Buy:

* Obtain the most up to date information available on the Pharmacogenomics projects globally.* Identify growth segments and opportunities in the industry.* Facilitate decision-making on the basis of strong historical and outlook of Pharmacogenomics data.* Develop business strategies with the help of specific insights about the planned and announced Pharmacogenomics projects globally.* Keep abreast of key new-build Pharmacogenomics projects globally.* Assess your competitors planned and Pharmacogenomics projects and capacities.

Additionally, the report is joined by a vital examination of the Pharmacogenomics marketplace considering progress, part commitments, and future market forecasts. Furthermore, it offers detailed data of vendors including the profile, specifications of a product, sales, applications, annual performance in the industry, investments, acquisitions and mergers, market size, revenue, market share, and more. The report also studies individual regional market size along with country-wise and region-wise market size during the forecast period. The report also understands the export and import, production, and consumption of every particular region holding the highest market share, market size, or CAGR.

Conclusively, This report will provide you a clear view of each and every fact of the market without a need to refer to any other research report or a data source. Our report will provide you with all the facts about the past, present, and future of the concerned Market.

Note: *The discount is offered on the Standard Price of the report.

Enquire here get customization & check discount, please click: https://www.coherentmarketinsights.com/insight/request-discount/1053

If you wish to find more details of the report or want a Customization Please contacts us. You can get a detailed of the entire research here.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website http://www.coherentmarketinsights.com

Contact:

Coherent Market Insights1001 4th Ave, #3200 Seattle, WA 98154, U.S.Email: sales@coherentmarketinsights.comUnited States of America: +1-206-701-6702United Kingdom: +44-020-8133-4027Japan: +050-5539-1737India: +91-848-285-0837

See the article here:
Covid 19 Analysis On Pharmacogenomics Market Growth in Business Future Scenarios and Brief Analysis of Top Key Players Thermo Fisher Scientific Inc.,...

The Global Pharmacogenomics Market report gives a detailed overview of the key market drivers, restraints, and trends and analyzes the way they will affect markets development over the forecast period 2020-2027

This Global Pharmacogenomics Industry 2020 report also gives comprehensive insight of , in-depth overview of the competitive landscape of the Pharmacogenomics Market, Industry Size, Share, Market Productions, Pricing, Global Revenues 2018-2020 Import-Export Figures & SWOT Analysis, PEST analysis, PORTER analysis and Forecast till 2027

Get/Download Free sample report,(Including COVID19 Impact Analysis, full TOC, Tables and Figures) @https://www.reportspedia.com/report/life-sciences/2015-2027-global-pharmacogenomics-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/58762#request_sample

Pharmacogenomics Market Influencing Factors:

Pharmacogenomics Market Forecast (2020-2027):

(Exclusive Offer: Up to 20% discount on this report):- Ask For Discount https://www.reportspedia.com/discount_inquiry/discount/58762

The leading players of Pharmacogenomics market includes

Bayer AGBecton, Dickinson and CompanyAffymetrix, Inc.F. Hoffmann-La Roche AGQIAGENAbbott Laboratories, Inc.Bio-Rad Laboratories, Inc.Thermo Fisher Scientific Inc.Illumina, Inc.AstraZeneca PLC

Pharmacogenomics Market Segmentation

Type Analysis of Pharmacogenomics Market:

DNA SequencingMicroarray, Polymerase Chain ReactionElectrophoresisMass SpectrometryOthers

Applications Analysis of Pharmacogenomics Market:

Drug DiscoveryTailored TreatmentOncologyPain ManagementOther Therapeutic Applications

Any Quries Or Customization? Do Inquiry Here https://www.reportspedia.com/report/life-sciences/2015-2027-global-pharmacogenomics-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/58762#inquiry_before_buying

Globally, Pharmacogenomics market spread across-

1. North America Country (United States, Canada)

2. South America

3. Asia Country (China, Japan, India, Korea)

4. Europe Country (Germany, UK, France, Italy)

5. Other Country (Middle East, Africa, GCC)

Segment 1. Pharmacogenomics Market Overview, Market Scope, Size Estimation, and Market Segmentation.

Segment 2. Pharmacogenomics Growth Drivers, Opportunities, Emerging Segments, and Industry Plans and Policies are explained.

Segment 3. Pharmacogenomics Industry Chain Analysis Explaining Manufacturing Base, Market Share, Product Type, Upstream Raw Materials Suppliers, and Downstream Buyers Is Covered.

Segment 4. Pharmacogenomics segmentation by type explains growth rate , and value from 2015-2020

Segment 5. Pharmacogenomics segmentation by application and regions covers consumption, growth rate, market share, price, and gross margin analysis.

Segment 6. Production, Consumption, Import-Export analysis of Pharmacogenomics by regions is explained.

Segment 7. Market Status and regional SWOT Analysis, PEST analysis, PORTER analysis are described.

Segment 8. Competitive landscape structure of top Pharmacogenomics players, gross margin analysis, price, and production value is specified.

Segment 9. Pharmacogenomics market analysis forecast by volume, value, consumption from 2020-2027 is provided for type, application, and region.

Segment 10. Pharmacogenomics Market maturity analysis, consumption forecast, feasibility study, and valuable Insight.

For more Information or Browse the complete report @https://www.reportspedia.com/report/life-sciences/2015-2027-global-pharmacogenomics-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/58762#table_of_contents

Go here to see the original:
Global Pharmacogenomics Market is Poised To Achieve Continuing Growth During Forecast Period 2020-2027 - 3rd Watch News

The National Human Genome Research Institute definesgenomic medicine asan emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., fordiagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use. Genomic medicine is a type of precision medicine in which genomics, epigenomics and other related data is used to accurately aid in individual disease diagnosis. Genomic medicine has novel applications in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious disease.Genomic medicine paves way for personalized medicine into clinics and has immense potential to reach the physicians and patients. Genomic medicine has been used for advanced sequencing in cancer pharmacogenomics, rare disorder diagnosis and for tracking of outbreaks of infectious diseases.

To remain ahead of your competitors, request for a sample [emailprotected] https://www.persistencemarketresearch.com/samples/11323

Genomic Medicine Market: Drivers & Restraints

Backed by government investments in precision medicine initiatives such as a multimillion dollar investment by President Obama in January 2015 which aims to improve how to treat and prevent a disease by laying emphasis on its genetic makeup is expected to boost the market growth. Clinical validity and utility of genomic medicine tests is a major issue witnessed in the global market. Also, lack of awareness among healthcare professionals, sluggish adoption of genome medicine, fluctuating regulatory landscape are the factors which could hamper growth of the global genomic medicine market.

Genomic Medicine Market: Segmentation

The global genomic medicine market is classified on the basis of application type, end use and region.

Based on application, the global genomic medicine market is segmented into the following:

Based on end use, the global genomic medicine market is segmented into the following:

To receive Methodology request here@ https://www.persistencemarketresearch.com/methodology/11323

Genomic Medicine Market: Overview

Genomic medicine is gaining momentum with expanding applications ranging from risk assessment and diagnosis in healthy individuals to genome-based treatment for patients with complicated disorders. Oncology is a major application of genomics medicine during cancer screening process as diagnostics for genetic and genomic markers. Oncology segment is expected to account for a major share in the global genomic medicine market. Genomic medicine is increasingly being used not only for research purpose but also in clinical applications. In clinical applications, genomic medicine will potentially enhance patient care.

Genomic Medicine Market: Region wise Overview

Geographically, global Genomic Medicine market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, Middle East and Africa (MEA). Owing to the presence of large number of academic as well as research institutions in the U.S. which are working on genomic medicine to discover next-generation genomic medicines, North America region is projected to lead the global genomic market in terms of value during the forecast period. Also, the presence of several universities offering educational programs coupled with opportunities in scientific research of genomic medicine in the North America and Europe is expected to have positive impact on the regional markets. The genomic medicine concept still in its nascent stage is yet to receive an impetus from the emerging market which are anticipated to hold smaller shares in the global market.

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/11323

Genomic Medicine Market: Key Players

The key research institutes in global genomic medicine market are

The focus of the top players will be on the identification of effective drug candidates particularly in cancer treatment based on the molecular structure of tumors.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, accessories and applications.

Here is the original post:
Global Genomic Medicine Market to Witness Stellar Growth Rate in the Next 10 Years - Jewish Life News

Prophecy Market Insights Pharmacogenomics market research report provides a comprehensive, 360-degree analysis of the targeted market which helps stakeholders to identify the opportunities as well as challenges during COVID-19 pandemic across the globe.

Pharmacogenomics Devices Market reports provide in-depth analysis of Top Players, Geography, End users, Applications, Competitor analysis, Revenue, Financial Analysis, Market Share, COVID-19 Analysis, Trends and Forecast 2020-2029. It incorporates market evolution study, involving the current scenario, growth rate, and capacity inflation prospects, based on Porters Five Forces and DROT analyses.

Get Sample Copy of This Report @ https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/244

An executive summary provides the markets definition, application, overview, classifications, product specifications, manufacturing processes; raw materials, and cost structures.

Market Dynamics offers drivers, restraints, challenges, trends, and opportunities of the Pharmacogenomics market

Detailed analysis of the COVID-19 impact will be given in the report, as our analyst and research associates are working hard to understand the impact of COVID-19 disaster on many corporations, sectors and help our clients in taking excellent business decisions. We acknowledge everyone who is doing their part in this financial and healthcare crisis.

Segment Level Analysis in terms of types, product, geography, demography, etc. along with market size forecast

Segmentation Overview:

The Pharmacogenomics research study comprises 100+ market data Tables, Graphs & Figures, Pie Chat to understand detailed analysis of the market. The predictions estimated in the market report have been resulted in using proven research techniques, methodologies, and assumptions. This Pharmacogenomics market report states the market overview, historical data along with size, growth, share, demand, and revenue of the global industry.

Request Discount @ https://www.prophecymarketinsights.com/market_insight/Insight/request-discount/244

Regional and Country- level Analysis different geographical areas are studied deeply and an economical scenario has been offered to support new entrants, leading market players, and investors to regulate emerging economies. The top producers and consumers focus on production, product capacity, value, consumption, growth opportunity, and market share in these key regions, covering

The comprehensive list of Key Market Players along with their market overview, product protocol, key highlights, key financial issues, SWOT analysis, and business strategies. The report dedicatedly offers helpful solutions for players to increase their clients on a global scale and expand their favour significantly over the forecast period. The report also serves strategic decision-making solutions for the clients.

Competitive landscape Analysis provides mergers and acquisitions, collaborations along with new product launches, heat map analysis, and market presence and specificity analysis.

PharmacogenomicsMarket Key Players:

Thermo Fisher Scientific Inc., Qiagen N.V., F.Hoffmann-La Roche AG, Abbot Laboratories, Diatech Pharmacogenetics, and Assurex Health Inc.

The study analyses the manufacturing and processing requirements, project funding, project cost, project economics, profit margins, predicted returns on investment, etc. With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Stakeholders Benefit:

Get In-depth TOC @ https://www.prophecymarketinsights.com/market_insight/Global-Pharmacogenomics-Market-By-Technology-244

About us:

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Contact Us:

Mr Alex (Sales Manager)

Prophecy Market Insights

Phone: +1 860 531 2701

Email: [emailprotected]

VISIT MY BLOG:- https://prophecyconsumerelectronics.blogspot.com/

The rest is here:
Pharmacogenomics Market: Predictable To Witness Sustainable Evolution over 2020-2030 - Cole of Duty

COVINGTON, Ky., July 1, 2020 /PRNewswire/ --Gravity Diagnostics, a CLIA laboratory headquartered in Covington, Kentucky, today announced the U.S. Food and Drug Administration (FDA) has granted an update to their Emergency Use Authorization (EUA) to include use of nasal swab specimens that are self-collected by individuals using the Kroger Health COVID-19 Test Home Collection Kit. This was an addition to their earlier EUA that was granted on June 1st, 2020. The testing solution combines the safety and convenience of at-home specimen collection with the expert guidance of a Kroger Health clinician through video telehealth visit.

On March 16th, Gravity Diagnostics began processing COVID-19 samples with a vision to bring increased testing to their local communities, partnering with the Commonwealth of Kentucky to serve the healthcare facilities across the state and later with Kroger Health to bring more testing to Kentucky and nationwide via drive through testing sites. This next big step with Kroger Health will allow the two organizations to make a more widespread impact for COVID-19 testing across the nation, through an innovative method focused on quality, compliance, and patient experience.

Kroger Health will make the kits available to frontline associates across Kroger's Family of Companies based on medical need first, and will expand rapidly from there, with a goal of processing up to 60,000 per week by the end of July. Gravity Diagnostics to date has processed over 250,000 COVID-19 samples. The relatively small laboratory is evolving quickly to meet the need and scale through hiring of personnel and expansion of equipment and new laboratory space.

"Everything we have done during this time is with the people of our communities and nation in mind. After partnering with Kroger Health to execute their nationwide drive throughs, we were enthusiastic to continue to expand testing through our partnership in a way that is flexible and accessible during this critical time of working to reopen the United States," said Tony Remington, CEO of Gravity Diagnostics. "We are humbled to be a part of just one of the ways Kroger Health is executing a larger vision of how the healthcare industry is evolving."

About Gravity DiagnosticsGravity Diagnostics is a full-service state-of-the-art CLIA laboratory licensed in all 50 states providing innovative laboratory testing including Infectious Disease (Upper Respiratory and Sexually Transmitted), Toxicology, and Pharmacogenomics. We are an advocate for physicians, patients, and our communities, supporting them with unsurpassed integrity, regulatory compliance, and clinical expertise. Learn more by visiting gravitydiagnostics.com.

About Kroger Health:Kroger Health, the healthcare division of The Kroger Co., is one of America's leading retail healthcare organizations, with over 2,000 pharmacies and 200 clinics in 35 states serving more than 14 million customers. Their team of 22,000 healthcare practitioners - from pharmacists and nurse practitioners, to dietitians and technicians are committed to helping people live healthier lives. They believe in practicing at the top of our licenses and enabling "food as medicine" to help prevent or manage certain diseases. Learn more atwww.krogerhealth.com.

About The Kroger Co.:At The Kroger Co. (NYSE: KR), we are Fresh for Everyone and dedicated to their Purpose: ToFeed the Human Spirit. They are, across our family of companies, nearly half a million associates who serve over 11 million customers daily through a seamless shopping experience under a variety ofbanner names. They are committed to creating #ZeroHungerZeroWaste communities by 2025. To learn more about them, visit theirnewsroomand investor relationssite.

Contact: media@gravitydiagnostics.com

Original post:
Gravity Diagnostics Partners with Kroger Health to Expand COVID-19 Testing with Home Collection Kits - News- Graphic